How many insider declarations does 云南白药 have?

云南白药 has filed 1 insider declaration with AMF.

Who is the top reporting insider at 云南白药?

The top reporting insider at 云南白药 is 董明, based on the count of public filings.

What is the net insider buy vs sell volume on 云南白药?

Across the available history, declared buys total 0 and disposals 0.

InsidersTradesSigma

← Companies ★ Sign in to follow

云

云南白药: directors' dealings · France · AMF

SZSE:000538FR·AMFMcap 101.3Bn€

AMF ↗

Explore the full directors' dealings record of 云南白药, a listed equity based in France. Shares are listed on FR FR, under the supervision of AMF. Market capitalisation: €101.3bn. The latest transaction was reported on 17 May 2022 — Purchase. Among the most active insiders: 董明. All data is accessible without an account.

1

Insider Decl.

0

Thresholds

·

1 ops.

Buy Volume

·

0 ops.

Sell Volume

Financial data

FY ended December 2025 · cache

50.86 €

Income statement

Revenue41.19 Bn€

Gross profit12.15 Bn€30% margin

Net income5.15 Bn€12.5% margin

Balance sheet & cash

Market cap101.27 Bn€

Total debt487.6 M€

Free Cash Flow4.12 Bn€

Last declaration on 17 May 2022

All Executives1 Thresholds Prospectus Other

Declarations0 total

No declarations found

0 of 0 declarations